Mp. Vawter et al., TRANSFORMING GROWTH-FACTORS BETA-1 AND BETA-2 IN THE CEREBROSPINAL-FLUID OF CHRONIC-SCHIZOPHRENIC PATIENTS, Neuropsychopharmacology, 16(1), 1997, pp. 83-87
Transforming growth factor betas (TGF beta s) are potent immunosuppres
sive molecules released in the brain after injury. We hypothesized tha
t TGF beta levels in cerebrospinal fluid (CSF) of schizophrenic patien
ts would be altered because TGF beta can influence neural cell adhesio
n moelecule (N-CAM) expression in vitro. The levels of TGF beta 1 and
beta 2 in CSF of patients with schizophrenia and normal controls measu
red by ELISA showed no differences. There was evidence that the stabil
ity of TGF beta in CSF may be altered in schizophrenia. For a limited
sample, TGF beta 1 and N-CAM concentrations were significantly correla
ted in normal patients (r = 0.98) but not in schizophrenics. The resul
ts do not support an active neurodegeneration or anti-inflammatory res
ponse in the central nervous system, which is reflected in the CSF of
chronic schizophrenics. (C) 1997 American College of Neuropsychopharma
cology.